Core Scientific (CORZ) Fundamental Analysis: Revenue, Earnings & Valuation

6.47 / 10

Outperform

Fundamental rating is Outperform with a 6.5/10 score. Key strengths include PB‑ROE, Profit‑MV, Cash‑MV and Net‑income‑Revenue, all in upper quartiles. Weaknesses are high inventory turnover days and a long operating cycle, while Revenue‑MV lags behind peers.

Analysis Checks(7/10)

Revenue-MV

Value-1.82

Score2/3

Weight17.35%

1M Return5.99%

Operating cycle

Value194.43

Score1/3

Weight-3.25%

1M Return-1.02%

Profit-MV

Value0.68

Score3/3

Weight32.29%

1M Return8.91%

Net income-Revenue

Value2.83

Score2/3

Weight1.76%

1M Return0.58%

PB-ROE

Value0.77

Score3/3

Weight37.30%

1M Return12.63%

Cash-UP

Value0.00

Score2/3

Weight-17.60%

1M Return-8.52%

Long-term debt to working capital ratio (%)

Value22.16

Score1/3

Weight0.39%

1M Return0.12%

Asset-MV

Value-0.55

Score1/3

Weight14.92%

1M Return4.13%

Inventory turnover days

Value210.83

Score2/3

Weight0.33%

1M Return0.11%

Cash-MV

Value0.32

Score3/3

Weight16.52%

1M Return5.94%

Is CORZ fundamentally strong?

CORZ scores 6.47/10 on fundamentals and holds a Discounted valuation at present. Backed by its 0.00% ROE, -90.47% net margin, -18.41 P/E ratio, -5.52 P/B ratio, and 81.93% earnings growth, these metrics solidify its Outperform investment rating.